ResourcesBlog2023 Biointron Year-End Networking and Game Night
2023 Biointron Year-End Networking and Game Night
Biointron2023-12-11Read time: 3 mins
On Friday December 8th, 2023, amidst a rich end-of-year festive atmosphere, The Tartufo Restaurant in Boston was brightly lit and bustling with energy, filled with bursts of joyful laughter and cheers.
On that night, Biointron held a special customer appreciation party. This party is dedicated to appreciating new and existing clients for the long-standing support and trust, and to looking forward to further collaborations.
We were honored to invite a host of partners and peers to attend this party. Mr. Zha Changchun, the CEO of Biointron, delivered a heartfelt speech, expressing gratitude to all the guests in attendance and conveying his appreciation for the continued support from our partners and industry colleagues over the years.
At the same time, the SVP of R&D, Dr. Shi Lei, presented a detailed report on the company's current business progress. He also provided an outlook for the future, giving attendees a deeper understanding of the prospects for Biointron.
During the evening, Dr. Janice Reichert from The Antibody Society shared the latest research achievements and future development trends in the antibody industry. Her excellent presentation not only included the cutting-edge technologies of the industry but also provided an in-depth analysis and forecast of the future development of the antibody industry.
Boris Xu, Biointron’s International Business Development Director, along with all colleagues also attended the party, joining together for this unforgettable evening.
At the end of the event, Biointron’s representatives expressed heartfelt thanks to each guest and promised to continue striving in the new year to provide clients with high-quality, economic, and high-speed antibody services. This party was not just a business event but also a sincere gesture of appreciation and commitment, showcasing Biointron's celebration for our customers. We look forward to a better future together with you!
In vivo research plays a pivotal role in the development of innovative therapeutics, particularly biologics. As researchers and drug developers continue to explore new targets and refine existing therapies, high-quality research tools like Benchmark Positive Antibodies are essential. These anti-huma
Antibodies have applications across research, diagnostics, and therapeutics. Their high specificity, selectivity, and ability to recognize and bind to specific antigens makes them essential for applications like selection, identification, purification, and disease treatment. Antibodies are generally categorized into two main groups: polyclonal antibodies (pAbs) and monoclonal antibodies (mAbs).
The 15th Annual World Bispecifics Summit 2024 was held in Boston, MA on September 3-5, 2024. The event brought together experts in the field of bi, tri and multi-specifics, in addition to bispecific ADCs and BiTEs.